Zipsor FDA Approval History
FDA Approved: Yes (First approved June 16, 2009)
Brand name: Zipsor
Generic name: diclofenac potassium
Dosage form: Capsules
Company: Xanodyne Pharmaceuticals, Inc.
Treatment for: Pain
Zipsor is a rapid release diclofenac potassium formulation for the treatment of patients with mild to moderate acute pain.
Development timeline for Zipsor
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.